Phase 1: Pain Management

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Sintetica
SinteticaSwitzerland - Mendriosi
1 program
1
Paracetamol 3%Phase 1/21 trial
Active Trials
NCT02654860Completed69Est. Feb 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
SinteticaParacetamol 3%

Clinical Trials (1)

Total enrollment: 69 patients across 1 trials

NCT02654860SinteticaParacetamol 3%

Dose-finding Study of Intrathecal Paracetamol Administered Immediately Before Spinal Anaesthesia

Start: Nov 2016Est. completion: Feb 201969 patients
Phase 1/2Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space